Director

Abraham Ceesay

Director (Chief Executive Officer, Rapport Therapeutics)·Charles River Laboratories International, Inc.

About

A

b

r

a

h

a

m

C

e

e

s

a

y

i

s

C

h

i

e

f

E

x

e

c

u

t

i

v

e

O

f

f

i

c

e

r

o

f

R

a

p

p

o

r

t

T

h

e

r

a

p

e

u

t

i

c

s

.

P

r

i

o

r

t

o

j

o

i

n

i

n

g

R

a

p

p

o

r

t

,

h

e

s

e

r

v

e

d

a

s

P

r

e

s

i

d

e

n

t

o

f

C

e

r

e

v

e

l

T

h

e

r

a

p

e

u

t

i

c

s

f

r

o

m

M

a

y

2

0

2

1

t

h

r

o

u

g

h

F

e

b

r

u

a

r

y

2

0

2

3

.

E

a

r

l

i

e

r

,

h

e

w

a

s

C

h

i

e

f

E

x

e

c

u

t

i

v

e

O

f

f

i

c

e

r

o

f

T

i

b

u

r

i

o

T

h

e

r

a

p

e

u

t

i

c

s

,

w

h

e

r

e

h

e

b

u

i

l

t

a

f

u

l

l

y

i

n

t

e

g

r

a

t

e

d

o

r

g

a

n

i

z

a

t

i

o

n

a

n

d

a

d

v

a

n

c

e

d

a

p

r

o

g

r

a

m

t

o

i

n

v

e

s

t

i

g

a

t

i

o

n

a

l

n

e

w

d

r

u

g

(

I

N

D

)

e

n

a

b

l

e

m

e

n

t

f

o

r

a

r

a

r

e

n

e

u

r

o

e

n

d

o

c

r

i

n

e

t

u

m

o

r

.

P

r

i

o

r

t

o

T

i

b

u

r

i

o

,

M

r

.

C

e

e

s

a

y

h

e

l

d

p

o

s

i

t

i

o

n

s

i

n

c

l

u

d

i

n

g

C

h

i

e

f

O

p

e

r

a

t

i

n

g

O

f

f

i

c

e

r

a

t

s

c

P

h

a

r

m

a

c

e

u

t

i

c

a

l

s

,

H

e

a

d

o

f

C

o

m

m

e

r

c

i

a

l

a

t

K

e

r

y

x

B

i

o

p

h

a

r

m

a

c

e

u

t

i

c

a

l

s

,

V

i

c

e

P

r

e

s

i

d

e

n

t

o

f

M

a

r

k

e

t

i

n

g

a

t

I

r

o

n

w

o

o

d

P

h

a

r

m

a

c

e

u

t

i

c

a

l

s

,

a

n

d

r

o

l

e

s

o

f

i

n

c

r

e

a

s

i

n

g

r

e

s

p

o

n

s

i

b

i

l

i

t

y

a

t

S

a

n

o

f

i

,

f

o

r

m

e

r

l

y

G

e

n

z

y

m

e

.

M

r

.

C

e

e

s

a

y

s

e

r

v

e

s

o

n

t

h

e

b

o

a

r

d

s

o

f

R

a

p

p

o

r

t

T

h

e

r

a

p

e

u

t

i

c

s

,

P

a

c

i

r

a

B

i

o

s

c

i

e

n

c

e

s

,

a

n

d

L

i

f

e

S

c

i

e

n

c

e

C

a

r

e

s

,

a

s

w

e

l

l

a

s

o

n

t

h

e

B

o

a

r

d

o

f

T

r

u

s

t

e

e

s

o

f

T

h

a

y

e

r

A

c

a

d

e

m

y

.

H

e

h

a

s

b

e

e

n

a

d

i

r

e

c

t

o

r

o

f

C

h

a

r

l

e

s

R

i

v

e

r

s

i

n

c

e

M

a

y

2

0

2

5

.

H

i

s

q

u

a

l

i

f

i

c

a

t

i

o

n

s

t

o

s

e

r

v

e

a

s

a

d

i

r

e

c

t

o

r

i

n

c

l

u

d

e

h

i

s

n

e

a

r

l

y

t

w

o

d

e

c

a

d

e

s

o

f

e

x

e

c

u

t

i

v

e

a

n

d

p

u

b

l

i

c

c

o

m

p

a

n

y

b

i

o

p

h

a

r

m

a

c

e

u

t

i

c

a

l

i

n

d

u

s

t

r

y

e

x

p

e

r

i

e

n

c

e

.

Since May 2025
Age 48
Tenure 1 yr

Also at Charles River Laboratories International, Inc.

JF James C. Foster Chair, President and Chief Executive Officer BG Birgit Girshick Corporate Executive Vice President and Chief Operating Officer (Chief Executive Officer effective May 5, 2026) NA Nancy C. Andrews Director (Executive Vice President and Chief Scientific Officer, Boston Children's Hospital) SB Steven Barg Director (Global Co-Head of Engagement, Elliott Investment Management L.P.) ME Mark Enyedy Director (Former President and Chief Executive Officer, ImmunoGen, Inc.) PG Paul Graves Director (Former Chief Executive Officer, Rio Tinto Lithium)

Roles

Organization Role Dates Details
Charles River Laboratories International, Inc. Director (Chief Executive Officer, Rapport Therapeutics) May 2025–present Current role
Rapport Therapeutics Chief Executive Officer present
Cerevel Therapeutics President May 2021 - Feb 2023
Tiburio Therapeutics Chief Executive Officer Built a fully integrated organization and advanced a program to IND enablement for a rare neuroendocrine tumor.
scPharmaceuticals Chief Operating Officer
Keryx Biopharmaceuticals Head of Commercial
Ironwood Pharmaceuticals Vice President of Marketing
Sanofi (formerly Genzyme) Roles of increasing responsibility

External roles

Organization Role Dates
Rapport Therapeutics Chief Executive Officer and Director
Pacira Biosciences Director
Life Science Cares Director
Thayer Academy Trustee

Related

Company Charles River Laboratories International, Inc. Company hub Person James C. Foster Chair, President and Chief Executive Officer Person Birgit Girshick Corporate Executive Vice President and Chief Operating Officer (Chief Executive Officer effective May 5, 2026) Person Nancy C. Andrews Director (Executive Vice President and Chief Scientific Officer, Boston Children's Hospital) Person Steven Barg Director (Global Co-Head of Engagement, Elliott Investment Management L.P.) Person Mark Enyedy Director (Former President and Chief Executive Officer, ImmunoGen, Inc.) Person Paul Graves Director (Former Chief Executive Officer, Rio Tinto Lithium) Person Reshema Kemps-Polanco Director (Executive Vice President and Chief Commercial Officer, Novartis US) Person George Llado, Sr. Director (Former Senior Vice President and Chief Information Officer, Alexion Pharmaceuticals, Inc.) Person Martin W. Mackay Director (Lead Independent Director; Co-Founder and Non-Executive Chair, Rallybio Corporation) Person Craig B. Thompson Director (President Emeritus and Former President and Chief Executive Officer, Memorial Sloan Kettering Cancer Center) Person Virginia M. Wilson Director (Retired Senior Executive Vice President and Chief Financial Officer, TIAA) Person Michael Knell Interim Chief Financial Officer, Corporate Senior Vice President, and Chief Accounting Officer Deal Charles River Laboratories International Agilux Laboratories 2016 Deal page Deal Charles River Laboratories International Argenta And Biofocus Cro Services Division Of Galapagos 2014 Deal page Deal Charles River Laboratories International Blue Stream Laboratories 2016 Deal page
Source: Charles River Laboratories International, Inc. SEC filings and official company website

See how VectorShift works for your firm

Request Demo